European Commission Approves Pfizer's Cibinqo® (abrocitinib) for the Treatment of Adults with Moderate-to-Severe Atopic DermatitisBusiness Wire • 12/10/21
This Vaccine Maker Can ‘Dominate' The Covid Market For Years To Come, Wells Fargo PredictsForbes • 12/09/21
FDA Expands Emergency Use Of Pfizer/BioNTech's COVID-19 Booster To 16 Years & OlderBenzinga • 12/09/21
Pfizer CEO says we may need a fourth vaccine dose to combat the Omicron variantBusiness Insider • 12/09/21
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 16 Years and OlderBusiness Wire • 12/09/21
The FDA says 16- and 17-year-olds can now get a Pfizer vaccine booster shotBusiness Insider • 12/09/21
Pfizer CEO says fourth Covid vaccine doses may be needed sooner than expected due to omicronCNBC • 12/08/21
Pfizer Is Making A Fortune From COVID - Objective Valuation Implies Strong Upside OpportunitySeeking Alpha • 12/08/21
Pfizer will submit full data on Covid treatment pill to the FDA in a few days, CEO saysCNBC • 12/08/21
Pfizer/BioNTech COVID-19 Shot Provides Partial Protection Against Omicron, Study ShowsBenzinga • 12/08/21
Pfizer says 3 of its shots work against Omicron, but that 2 are significantly less effectiveBusiness Insider • 12/08/21
Pfizer-BioNTech say booster dose provides high level of protection against omicron variantCNBC • 12/08/21
Pfizer, BioNTech say initial lab study showed 3 doses of COVID-19 vaccine neutralized omicron variantMarket Watch • 12/08/21